1. Home
  2. BSVN vs MYGN Comparison

BSVN vs MYGN Comparison

Compare BSVN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank7 Corp.

BSVN

Bank7 Corp.

N/A

Current Price

$55.97

Market Cap

632.6M

Sector

Finance

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$5.47

Market Cap

523.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BSVN
MYGN
Founded
2004
1991
Country
United States
United States
Employees
N/A
2700
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
632.6M
523.7M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
BSVN
MYGN
Price
$55.97
$5.47
Analyst Decision
Buy
Hold
Analyst Count
3
9
Target Price
★ $63.33
$5.90
AVG Volume (30 Days)
30.1K
★ 1.7M
Earning Date
10-15-2026
11-04-2026
Dividend Yield
★ 2.13%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 3.18
N/A
Revenue
N/A
★ $771,400,000.00
Revenue This Year
$10.97
N/A
Revenue Next Year
$54.28
N/A
P/E Ratio
$17.70
★ N/A
Revenue Growth
N/A
★ 2.33
52 Week Low
$38.29
$2.74
52 Week High
$60.17
$8.09

Technical Indicators

Market Signals
Indicator
BSVN
MYGN
Relative Strength Index (RSI) 36.86 46.99
Support Level $53.85 $4.19
Resistance Level $57.23 $5.52
Average True Range (ATR) 1.17 0.30
MACD -0.47 -0.13
Stochastic Oscillator 6.35 0.00

Price Performance

Historical Comparison
BSVN
MYGN

About BSVN Bank7 Corp.

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: